Cash & equivalents decreased 27.9%
Cash & equivalents changed -27.9% from the comparable as-filed period. The change ranks at the 44th percentile of 243 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -27.9% from the comparable as-filed period. The change ranks at the 44th percentile of 243 prior comparable changes.
Gross margin changed -304 basis points from the comparable as-filed period. The change ranks at the 66th percentile of 130 prior comparable changes.
Operating income changed -23.3% from the comparable as-filed period. The change ranks at the 28th percentile of 130 prior comparable changes.
Research & development changed -18.6% from the comparable as-filed period. The change ranks at the 33th percentile of 84 prior comparable changes.
Operating margin changed -103 basis points from the comparable as-filed period. The change ranks at the 7th percentile of 130 prior comparable changes.
Debt changed +0.0% from the comparable as-filed period. The change ranks at the 43th percentile of 14 prior comparable changes.
Gross profit changed -4.0% from the comparable as-filed period. The change ranks at the 8th percentile of 130 prior comparable changes.
Net income changed -1.5% from the comparable as-filed period. The change ranks at the 0th percentile of 167 prior comparable changes.
Revenue changed -0.1% from the comparable as-filed period. The change ranks at the 0th percentile of 130 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.